Related content

To Fund or Not to Fund: Development of a Decision-Making Framework for the Coverage of New Health Technologies

By Stafinski Tania  

PharmacoEconomics, Vol. 29, Iss. 9, 2011-09 ,pp. : 771-780

Adis International

Access to resources Recommend Favorite

Bill and Melinda Gates have pledged $US10 billion over the next 10 years to fund the development and delivery of vaccines.

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 596, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Development of a Reversed-Phase HPLC Impurity Method for a UV Variable Isomeric Mixture of a CRF Drug Substance Intermediate with the Assistance of Corona CAD

By Huang Zongyun  

Journal of Pharmaceutical Innovation, Vol. 6, Iss. 2, 2011-06 ,pp. : 115-123

Springer Publishing Company

Access to resources Recommend Favorite

Global Fund reaches China, Russia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 480, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Swiss to fund and evaluate complementary therapies

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 622, 2011-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite